Skip to main content
Top
Published in: Current Dermatology Reports 4/2023

14-09-2023 | Fecal Incontinence | REVIEW

Incontinence-Associated Dermatitis: a Practical Guide for the Consulting Dermatologist

Authors: Narges Maskan Bermudez, Brianna Christina Sa, Marita Yaghi, Abby Hargis, Scott A. Elman

Published in: Current Dermatology Reports | Issue 4/2023

Login to get access

Abstract

Purpose of Review

Incontinence-associated dermatitis (IAD) is a common irritant contact dermatitis associated with exposure to urine or feces. This review provides an overview of the etiology, diagnosis, and clinical management of IAD.

Recent Findings

Incontinent patients should follow a comprehensive preventive care regimen to minimize the occurrence of IAD. This regimen includes daily and as-needed cleansing using specialized “no-rinse” cleansers to cleanse the skin, remove irritants, and provide protection. Additionally, cleansers containing miconazole may be added to provide additional defense and reduce candidal infections. To reduce frictional irritation and preserve the skin barrier, it is recommended to minimize towel drying and apply an emollient moisturizer and skin protectant. Additionally, incorporating fecal collection devices or protective hydrocolloid dressings in combination with or as alternatives to adult containment briefs has proven effective in reducing the prevalence of IAD by minimizing exposure to moisture, irritants, and friction.

Summary

IAD causes significant discomfort and is a risk factor for pressure ulcers and skin infections. Elderly hospitalized patients and individuals with fecal incontinence are at a high risk for developing IAD. Diagnosing IAD can be challenging as it is often misdiagnosed as stage I and II pressure ulcers. Visual indicators of pressure ulcers include distinct lesions over bony prominences, non-blanchable erythema, and localized skin changes with or without necrosis. Prevention of IAD involves minimizing exposure to stool and/or urine and implementing a skincare regimen that includes gentle cleansing, moisturization, and application of a skin protectant.
Literature
4.
go back to reference Demarre L, Verhaeghe S, Van Hecke A, Clays E, Grypdonck M, Beeckman D. Factors predicting the development of pressure ulcers in an at-risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial. J Adv Nurs. 2015;71(2):391–403. https://doi.org/10.1111/jan.12497.CrossRefPubMed Demarre L, Verhaeghe S, Van Hecke A, Clays E, Grypdonck M, Beeckman D. Factors predicting the development of pressure ulcers in an at-risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial. J Adv Nurs. 2015;71(2):391–403. https://​doi.​org/​10.​1111/​jan.​12497.CrossRefPubMed
14.
go back to reference Beeckman D, Van den Bussche K, Alves P, et al. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol. 2018;178(6):1331–40. https://doi.org/10.1111/bjd.16327.CrossRefPubMed Beeckman D, Van den Bussche K, Alves P, et al. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol. 2018;178(6):1331–40. https://​doi.​org/​10.​1111/​bjd.​16327.CrossRefPubMed
24.
37.
go back to reference • Glass GF, Jr., Goh CCK, Cheong RQ, Ong ZL, Khong PCB, Chan EY. Effectiveness of skin cleanser and protectant regimen on incontinence-associated dermatitis outcomes in acute care patients: a cluster randomised trial. Int Wound J. 2021;18(6):862–873. https://doi.org/10.1111/iwj.13588. This study examined the effectiveness of a specialized skin cleanser and protectant regimen in treating incontinence-associated dermatitis (IAD) in acute care patients. The trial compared this regimen to the standard use of body wipes and a zinc oxide protectant. The results showed that the specialized regimen improved IAD healing within 7 days, especially in patients with skin loss, and that the overall risk of skin deterioration was reduced with the use of skin cleansers and protectants. These findings highlight the importance of incorporating specialized skin cleansers into the treatment of IAD in acute care settings and emphasize the need for a structured skin care regimen to prevent IAD skin deterioration. • Glass GF, Jr., Goh CCK, Cheong RQ, Ong ZL, Khong PCB, Chan EY. Effectiveness of skin cleanser and protectant regimen on incontinence-associated dermatitis outcomes in acute care patients: a cluster randomised trial. Int Wound J. 2021;18(6):862–873. https://​doi.​org/​10.​1111/​iwj.​13588. This study examined the effectiveness of a specialized skin cleanser and protectant regimen in treating incontinence-associated dermatitis (IAD) in acute care patients. The trial compared this regimen to the standard use of body wipes and a zinc oxide protectant. The results showed that the specialized regimen improved IAD healing within 7 days, especially in patients with skin loss, and that the overall risk of skin deterioration was reduced with the use of skin cleansers and protectants. These findings highlight the importance of incorporating specialized skin cleansers into the treatment of IAD in acute care settings and emphasize the need for a structured skin care regimen to prevent IAD skin deterioration.
38.
go back to reference Lewis-Byers K, Thayer D. An evaluation of two incontinence skin care protocols in a long-term care setting. Ostomy Wound Manage. 2002;48(12):44–51.PubMed Lewis-Byers K, Thayer D. An evaluation of two incontinence skin care protocols in a long-term care setting. Ostomy Wound Manage. 2002;48(12):44–51.PubMed
39.
go back to reference Hoggarth A, Waring M, Alexander J, Greenwood A, Callaghan T. A controlled, three-part trial to investigate the barrier function and skin hydration properties of six skin protectants. Ostomy Wound Manage. 2005;51(12):30–42.PubMed Hoggarth A, Waring M, Alexander J, Greenwood A, Callaghan T. A controlled, three-part trial to investigate the barrier function and skin hydration properties of six skin protectants. Ostomy Wound Manage. 2005;51(12):30–42.PubMed
40.
go back to reference • Zhang X, Wang X, Zhao X, Zhang Y. A structured skin care protocol for preventing and treating incontinence-associated dermatitis in critically Ill patients. Adv Skin Wound Care. 2022;35(6):335–342. https://doi.org/10.1097/01.ASW.0000828972.70137.8a. This study aimed to assess the effectiveness of a structured skin care protocol in preventing and treating IAD. The results showed that the application of the structured skin care protocol significantly reduced the incidence of IAD from 35.9 to 17.7% and decreased the severity of IAD. These findings demonstrate that the implementation of the structured skin care protocol effectively lowers the incidence and severity of IAD and delays its development in critically ill patients. • Zhang X, Wang X, Zhao X, Zhang Y. A structured skin care protocol for preventing and treating incontinence-associated dermatitis in critically Ill patients. Adv Skin Wound Care. 2022;35(6):335–342. https://​doi.​org/​10.​1097/​01.​ASW.​0000828972.​70137.​8a. This study aimed to assess the effectiveness of a structured skin care protocol in preventing and treating IAD. The results showed that the application of the structured skin care protocol significantly reduced the incidence of IAD from 35.9 to 17.7% and decreased the severity of IAD. These findings demonstrate that the implementation of the structured skin care protocol effectively lowers the incidence and severity of IAD and delays its development in critically ill patients.
41.
go back to reference Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs Nov-Dec. 2011;38(6):627–34. https://doi.org/10.1097/WON.0b013e31822efe52.CrossRef Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs Nov-Dec. 2011;38(6):627–34. https://​doi.​org/​10.​1097/​WON.​0b013e31822efe52​.CrossRef
43.
go back to reference Li Q, Zhu D, Liu Y, Qin L, Long X, Yu X. Efficacy of modified isolation in incontinence associated dermatitis. Am J Transl Res. 2023;15(2):1326–33.PubMedPubMedCentral Li Q, Zhu D, Liu Y, Qin L, Long X, Yu X. Efficacy of modified isolation in incontinence associated dermatitis. Am J Transl Res. 2023;15(2):1326–33.PubMedPubMedCentral
44.
go back to reference • Zhang Y, Leng M, Guo J, Duan J, Wang Z. The effectiveness of faecal collection devices in preventing incontinence-associated dermatitis in critically ill patients with faecal incontinence: a systematic review and meta-analysis. Aust Crit Care. 2021;34(1):103–112. https://doi.org/10.1016/j.aucc.2020.04.152. This article presents a systematic review and meta-analysis that examines the effects of different types of fecal collection devices on incontinence-associated dermatitis (IAD) in critically ill patients with fecal incontinence. The findings indicate that the use of fecal collection devices significantly reduces the incidence of IAD. • Zhang Y, Leng M, Guo J, Duan J, Wang Z. The effectiveness of faecal collection devices in preventing incontinence-associated dermatitis in critically ill patients with faecal incontinence: a systematic review and meta-analysis. Aust Crit Care. 2021;34(1):103–112. https://​doi.​org/​10.​1016/​j.​aucc.​2020.​04.​152. This article presents a systematic review and meta-analysis that examines the effects of different types of fecal collection devices on incontinence-associated dermatitis (IAD) in critically ill patients with fecal incontinence. The findings indicate that the use of fecal collection devices significantly reduces the incidence of IAD.
47.
go back to reference Beeckman D, Campbell J, Campbell K, et al. Incontinence-associated dermatitis: moving prevention forward. 02/13 2015; Beeckman D, Campbell J, Campbell K, et al. Incontinence-associated dermatitis: moving prevention forward. 02/13 2015;
Metadata
Title
Incontinence-Associated Dermatitis: a Practical Guide for the Consulting Dermatologist
Authors
Narges Maskan Bermudez
Brianna Christina Sa
Marita Yaghi
Abby Hargis
Scott A. Elman
Publication date
14-09-2023
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 4/2023
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-023-00403-x

Other articles of this Issue 4/2023

Current Dermatology Reports 4/2023 Go to the issue